Teladoc Health, Inc.
TDOC
$5.35
-$0.17-3.08%
NYSE
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 2.53% | -0.86% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 2.53% | -0.86% | |||
| Cost of Revenue | 5.27% | -1.76% | |||
| Gross Profit | 1.36% | -0.48% | |||
| SG&A Expenses | -4.09% | -2.10% | |||
| Depreciation & Amortization | 7.32% | -4.98% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.11% | -2.37% | |||
| Operating Income | 23.94% | 22.98% | |||
| Income Before Tax | 33.06% | -24.24% | |||
| Income Tax Expenses | -1,085.31% | 90.79% | |||
| Earnings from Continuing Operations | 49.21% | -51.58% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 49.21% | -51.58% | |||
| EBIT | 23.94% | 22.98% | |||
| EBITDA | 168.50% | 299.21% | |||
| EPS Basic | 49.46% | -50.67% | |||
| Normalized Basic EPS | 27.46% | -4.57% | |||
| EPS Diluted | 49.46% | -50.67% | |||
| Normalized Diluted EPS | 27.46% | -4.57% | |||
| Average Basic Shares Outstanding | 0.51% | 0.58% | |||
| Average Diluted Shares Outstanding | 0.51% | 0.58% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||